Health News

Treelet Health provides the latest health news, disease prevention, nutrition and diet, and other professional health knowledge to help you maintain a healthy lifestyle.

AI-Designed Drug Shifts Blood Profiles Toward Younger Biological Age in Lung Disease Patients
Global Health 2026-09-14

AI-Designed Drug Shifts Blood Profiles Toward Younger Biological Age in Lung Disease Patients

A study published in Nature Biotechnology reveals that rentosertib, an AI-designed drug for idiopathic pulmonary fibrosis, shifted patients' blood protein patterns toward a younger biological age across six independent aging clocks. However, researchers caution this does not prove patients became younger or will live longer, and larger, longer trials are needed.

Why Are Americans So Tired So Often? New CDC Report Highlights Who Is Feeling It Most
Global Health 2026-09-14

Why Are Americans So Tired So Often? New CDC Report Highlights Who Is Feeling It Most

A new CDC report reveals that about 71.5% of U.S. adults experienced fatigue on multiple days in the past three months, with nearly 1 in 6 feeling exhausted most or every day. Women, younger adults, and American Indian/Alaska Native adults report the highest rates. Fatigue is not just sleepiness—it's linked to anxiety, depression, chronic illness, and life stress.

Can Junk Food Trigger Fatty Liver? Understanding NAFLD and Metabolic Health Risks
Global Health 2026-09-13

Can Junk Food Trigger Fatty Liver? Understanding NAFLD and Metabolic Health Risks

Junk food is a major contributor to non-alcoholic fatty liver disease (NAFLD). High fructose, saturated fats, and refined carbohydrates promote liver fat accumulation through mechanisms like insulin resistance. This article examines the latest research on the link between fast food and fatty liver, offering science-based prevention strategies.

Is Mouthwash Bad for Your Oral Health? Research Links Daily Use to Microbiome Disruption
Global Health 2026-09-12

Is Mouthwash Bad for Your Oral Health? Research Links Daily Use to Microbiome Disruption

Social media claims warn that regular mouthwash use can disrupt the oral microbiome and raise risks of Type 2 diabetes, high blood pressure, and heart disease. Experts say occasional use is fine, but long-term, frequent use of antiseptic rinses containing chlorhexidine may alter oral ecology and affect blood pressure regulation. Here's what the research actually shows.

Semaglutide Slows Ageing and Extends Lifespan in Mice, Study Finds
Global Health 2026-09-12

Semaglutide Slows Ageing and Extends Lifespan in Mice, Study Finds

A new study published in Nature found that semaglutide not only aids weight loss and blood sugar control but also slows multiple ageing markers and extends lifespan in older female mice. However, researchers stress that long-term human trials are still needed to confirm these effects.

NHS England Expands Pharmacy First: Migraines, Acne, Ear Infections and 2 Other Conditions Now Treatable at Pharmacies Without a GP Appointment
Global Health 2026-09-10

NHS England Expands Pharmacy First: Migraines, Acne, Ear Infections and 2 Other Conditions Now Treatable at Pharmacies Without a GP Appointment

NHS England is expanding its Pharmacy First scheme so patients can walk into participating high street pharmacies for on-the-spot treatment of migraines, acne, scabies, ear infections and rhinitis — without needing a GP appointment first. The move aims to ease pressure on GPs and A&E and could redirect 2–3 million consultations a year.

New Breakthrough in Narcolepsy Type 1: Oveporexton Phase 3 Data Published in NEJM, Targeting the Root Cause of Daytime Sleepiness and Cataplexy
Global Health 2026-09-10

New Breakthrough in Narcolepsy Type 1: Oveporexton Phase 3 Data Published in NEJM, Targeting the Root Cause of Daytime Sleepiness and Cataplexy

Takeda announced results from two Phase 3 studies of Oveporexton (ORZEYFUL), an oral orexin receptor 2 agonist, showing significant improvements in excessive daytime sleepiness, cataplexy, disrupted nighttime sleep, and quality of life in patients with narcolepsy type 1, with a favorable safety profile. The drug is now approved in the U.S., China, and Japan.

Showing 25 - 36 of 725 articles